193 related articles for article (PubMed ID: 14530304)
1. The molecular biology of mucosal field cancerization of the head and neck.
Ha PK; Califano JA
Crit Rev Oral Biol Med; 2003; 14(5):363-9. PubMed ID: 14530304
[TBL] [Abstract][Full Text] [Related]
2. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?
van Oijen MG; Slootweg PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):249-56. PubMed ID: 10750662
[TBL] [Abstract][Full Text] [Related]
3. p53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients.
Escher A; Piotet E; Waridel F; Iggo R; Monnier P
Eur Arch Otorhinolaryngol; 2009 Apr; 266(4):547-51. PubMed ID: 18688630
[TBL] [Abstract][Full Text] [Related]
4. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
6. Genetic progression model for head and neck cancer: implications for field cancerization.
Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
[TBL] [Abstract][Full Text] [Related]
7. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
[TBL] [Abstract][Full Text] [Related]
8. The origins of multiple squamous cell carcinomas in the aerodigestive tract.
van Oijen MG; Leppers Vd Straat FG; Tilanus MG; Slootweg PJ
Cancer; 2000 Feb; 88(4):884-93. PubMed ID: 10679659
[TBL] [Abstract][Full Text] [Related]
9. Recurrences and second primary tumours in the head and neck region: differentiation by p53 mutation analysis.
Gasparotto D; Maestro R; Barzan L; Vukosavljevic T; Doglioni C; Sulfaro S; Piccinin S; Boiocchi M
Ann Oncol; 1995 Nov; 6(9):933-9. PubMed ID: 8624298
[TBL] [Abstract][Full Text] [Related]
10. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
Califano J; Leong PL; Koch WM; Eisenberger CF; Sidransky D; Westra WH
Clin Cancer Res; 1999 Jul; 5(7):1862-7. PubMed ID: 10430093
[TBL] [Abstract][Full Text] [Related]
11. Multiple oral squamous epithelial lesions: are they genetically related?
Jang SJ; Chiba I; Hirai A; Hong WK; Mao L
Oncogene; 2001 Apr; 20(18):2235-42. PubMed ID: 11402318
[TBL] [Abstract][Full Text] [Related]
12. Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers.
van Zeeburg HJ; Graveland AP; Brink A; Nguyen M; Leemans CR; Bloemena E; Braakhuis BJ; Brakenhoff RH
Head Neck; 2013 Apr; 35(4):568-74. PubMed ID: 22714984
[TBL] [Abstract][Full Text] [Related]
13. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability as biomarker for risk of multiple primary malignancies of the upper aerodigestive tract.
Sardi I; Franchi A; Bocciolini C; Mechi C; Frittelli A; Bruschini L; Gallo O
Oncol Rep; 2001; 8(2):393-9. PubMed ID: 11182062
[TBL] [Abstract][Full Text] [Related]
16. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
17. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.
Califano J; Westra WH; Koch W; Meininger G; Reed A; Yip L; Boyle JO; Lonardo F; Sidransky D
J Natl Cancer Inst; 1999 Apr; 91(7):599-604. PubMed ID: 10203278
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?
Deganello A; Franchi A; Sardi I; Pignataro L; Leemans CR; Gallo O
Cancer; 2010 Mar; 116(5):1291-7. PubMed ID: 20087960
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.
Papadimitrakopoulou VA; Shin DM; Hong WK
Cancer Metastasis Rev; 1996 Mar; 15(1):53-76. PubMed ID: 8842479
[TBL] [Abstract][Full Text] [Related]
20. Field cancerization: concept and clinical implications in head and neck squamous cell carcinoma.
Jaiswal G; Jaiswal S; Kumar R; Sharma A
J Exp Ther Oncol; 2013; 10(3):209-14. PubMed ID: 24416996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
